BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Drug Development

  Genta Incorporated Receives Scientific Advice from European Medicines Evaluation Agency Supporting Randomized Phase 3 Trial of Tesetaxel in Patients with Advanced Gastric Cancer

  November 1, 2010

   · 

  1 min read
• Drug Development

  Synta Pharmaceuticals Announces Gynecologic Oncology Group (GOG) to Initiate Phase 2 Clinical Trial of Elesclomol for the Treatment of Ovarian Cancer

  November 1, 2010

   · 

  1 min read
• Business

  Dyadem Continues European Expansion with the Opening of an Office in Germany

  November 1, 2010

   · 

  1 min read
• FDA

  APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP

  November 1, 2010

   · 

  1 min read
• Business

  RainDance Technologies Strengthens Leadership Team with Key Appointments

  November 1, 2010

   · 

  1 min read
• Business

  Pernix Therapeutics, Inc. to Report Third Quarter 2010 Results on November 12, 2010

  November 1, 2010

   · 

  1 min read
• FDA

  Phytoceuticals Ltd. Receives CE Mark for 1 Primary Wound Dressing, Designed to be an ‘All-Rounder’ First Choice Product Making Successful Wound-Healing Easy

  November 1, 2010

   · 

  3 min read
• Biotech Bay

  El Camino Hospital Physicians Launch Trial to Find Early Diagnosis Tool for Lung Cancer

  November 1, 2010

   · 

  1 min read
• Business

  XenoPort, Inc. to Release Third Quarter Financial Results on November 8, 2010

  November 1, 2010

   · 

  1 min read
• Business

  HepaLife Technologies Inc. Launches Alliqua BioMedical to Capitalize on New Market Opportunities

  November 1, 2010

   · 

  7 min read